Lung cancer is the leading cause of cancer-related death in the United States. An estimated
219,440 new cases (116,090 men; 103,350 women) of lung and bronchus cancer were …

This article proposes codes for the primary tumor categories of adenocarcinoma in situ (AIS)
and minimally invasive adenocarcinoma (MIA) and a uniform way to measure tumor size in …

Small cell lung cancer (SCLC) is one of the four major histological types of lung cancer. The
incidence of SCLC in developed countries has declined in recent years, presumably …

The IASLC Staging and Prognostic Factors Committee has collected a new database of
94,708 cases donated from 35 sources in 16 countries around the globe. This has now been …

Purpose To determine the safety, dosing schedules, pharmacokinetic profile, and biologic
effect of orally administered histone deacetylase inhibitor suberoylanilide hydroxamic acid (…

These NCCN Guidelines Insights focus on the diagnostic evaluation of suspected lung
cancer. This topic was the subject of a major update in the 2013 NCCN Clinical Practice …

Purpose Neoadjuvant pemetrexed plus cisplatin was administered, followed by extrapleural
pneumonectomy (EPP) and hemithoracic radiation (RT), to assess the feasibility and efficacy …

Introduction Revisions to the TNM stage classifications for lung cancer, informed by the
international database (N = 94,708) of the International Association for the Study of Lung Cancer (…

Introduction Small cell lung cancer (SCLC) is commonly classified as either limited or extensive,
but the Union for International Cancer Control TNM Classification of Malignant Tumours …

Most patients with non–small cell lung cancer (NSCLC) are diagnosed with advanced
cancer. These guidelines only include information about stage IV NSCLC. Patients with …